芳香疗法对门诊腹部手术患者出院后恶心症状的治疗效果

The Efficacy of Aromatherapy in the Treatment of Postdischarge Nausea in Patients Undergoing Outpatient Abdominal Surgery.

作者信息

Mcilvoy Laura, Richmer Linda, Kramer Deborah, Jackson Rita, Shaffer Leslee, Lawrence Jeffrey, Inman Kevin

出版信息

J Perianesth Nurs. 2015 Oct;30(5):383-8. doi: 10.1016/j.jopan.2014.10.004.

DOI:10.1016/j.jopan.2014.10.004

PMID:26408512

Abstract

PURPOSE

The purpose of this study was to explore the effectiveness of the aromatherapy product QueaseEASE (QE) for decreasing postdischarge nausea (PDN) in patients undergoing outpatient abdominal surgery.

DESIGN

Prospective exploratory study.

METHODS

Informed Consent was obtained preoperatively from a convenience sample of adult patients scheduled for outpatient abdominal surgery procedures. Prior to discharge, subjects were instructed in the use of QE and given instructions on how to rate their nausea on a 0-10 scale. They recorded nausea scales > 0 any time they occurred for the next 24 hours, used the QE, and recorded their nausea scales 3 minutes later. A study nurse called subjects the next day to collect the information.

FINDINGS

The sample included 70 outpatients who underwent abdominal surgery. Twenty-five participants (36%) reported experiencing PDN and their concomitant use of QE. There was a significant difference in mean age of those reporting PDN (37 years) versus those without nausea (48 years, P = .004) as well as a significant difference in mean intravenous fluid intake during hospitalization of those reporting PDN (1,310 mL) versus those without nausea (1,511 mL, P = .04). The PDN group had more female participants (72% vs 42%, P = .02), more participants that were less than 50 years of age (84% vs 53%, P = .02), and received more opioids (100% vs 76%, P = .006) than the no nausea group. The 25 PDN participants reported 47 episodes of PDN in which they used QE. For all of the 47 PDN episodes experienced, participants reported a decrease in nausea scale (0 to 10) after the use of QE; for 22 (47%) of the PDN episodes experienced, a nausea scale of 0 after using QE was reported. The mean decrease in nausea scale for all 25 participants was 4.78 (±2.12) after using QE.

CONCLUSION

This study found that the aromatherapy QE was an effective treatment of PDN in select same-day abdominal surgery patients.

摘要

目的

本研究旨在探讨芳香疗法产品QueaseEASE（QE）对减少门诊腹部手术患者出院后恶心（PDN）的有效性。

设计

前瞻性探索性研究。

方法

从计划进行门诊腹部手术的成年患者便利样本中，术前获取知情同意书。出院前，指导受试者使用QE，并告知他们如何在0至10分的量表上对恶心程度进行评分。他们在接下来的24小时内，每当恶心量表评分>0时进行记录，使用QE，并在3分钟后记录恶心量表评分。次日，研究护士致电受试者收集信息。

结果

样本包括70例接受腹部手术的门诊患者。25名参与者（36%）报告经历了PDN并同时使用了QE。报告有PDN的患者平均年龄（37岁）与无恶心症状的患者（48岁）之间存在显著差异（P = 0.004），报告有PDN的患者住院期间平均静脉输液量（1310毫升）与无恶心症状的患者（1511毫升）之间也存在显著差异（P = 0.04）。PDN组女性参与者更多（72%对42%，P = 0.02），年龄小于50岁的参与者更多（84%对53%，P = 0.02），且比无恶心组接受了更多的阿片类药物（100%对76%，P = 0.006）。25名PDN参与者报告了47次使用QE的PDN发作。对于所有经历的47次PDN发作，参与者报告使用QE后恶心量表评分下降；对于22次（47%）经历的PDN发作，报告使用QE后恶心量表评分为0。所有25名参与者使用QE后恶心量表评分的平均下降值为4.78（±2.12）。